New President and CEO of Bio Ventures for Global Health

BIO Ventures for Global Health (BVGH) has announced that Christopher D. Earl, PhD, a leading venture capitalist and entrepreneur in the biotechnology industry, has been appointed president, chief executive officer and director of BVGH. Dr. Earl was previously managing director at the Perseus-Soros BioPharmaceutical Fund. BVGH was founded in 2004 with the support of the Biotechnology Industry Organization (BIO), the Bill & Melinda Gates Foundation and the Rockefeller Foundation to focus the resources of the biotechnology industry on the most urgent medical challenges of the developing world.Dr. Earl has 20 years of experience in biotechnology entrepreneurship. Before joining the Perseus-Soros BioPharmaceutical Fund, LP, a prominent private equity firm investing in later-stage life science companies, Dr. Earl was president and CEO of Avitech Diagnostics, Inc., and a general partner at Plant Resources Venture Funds. Dr. Earl received a BA in biology from the University of Pennsylvania, and a PhD in cellular and developmental biology from Harvard University.BIO Ventures for Global Health aims to break down barriers that hinder development of new vaccines, drugs, and diagnostics to treat the urgent medical needs of the developing world. Working globally with partners in the for-profit and non-profit sectors, BVGH is building market-based solutions to catalyze industry investment in global health innovations. BVGH devotes its expertise in the business and science of biotechnology product development to improving the lives of people in the neediest regions of the world.